Parent Drug and Active Metabolite (FDA) [Regulatives / Guidelines]

posted by joyjac – Philippines, 2006-05-10 07:44 (6554 d 04:29 ago) – Posting: # 122
Views: 8,046

Dear HS,

Just to clarify in case of (2): 90% CI will be applied to the parent drug and present the metabolite data descriptively - would this mean that ANOVA on the metabolite data is not necessary?

Thanks for sharing your expertise.
Joy

Complete thread:

UA Flag
Activity
 Admin contact
22,987 posts in 4,824 threads, 1,662 registered users;
91 visitors (0 registered, 91 guests [including 4 identified bots]).
Forum time: 12:14 CEST (Europe/Vienna)

The only way to comprehend what mathematicians mean by Infinity
is to contemplate the extent of human stupidity.    Voltaire

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5